25:16Eli Lilly Alzheimer's Drug Fails Major Test Trial
From the creator
A drug developed by Eli Lilly to treat patients with Alzheimer's disease symptoms failed a closely watched clinical trial. WSJ's Jeanne Whalen explains the impact of the failure on Eli Lilly stock and the rest of the pharmaceutical sector, which had rested its hopes on the success of the drug. Photo: Kris Tripplaar/Sipa USA Subscribe to the WSJ channel here: http://bit.ly/14Q81Xy More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com Follow WSJ on Facebook: http://www.facebook.com/wsjvideo Follow WSJ on Google+: https://plus.google.com/+wsj/posts Follow WSJ on Twitter: https://twitter.com/WSJvideo Follow WSJ on Instagram: http://instagram.com/wsj Follow WSJ on Pinterest: http://www.pinterest.com/wsj/ Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy More from the Wall Street Journal: Visit WSJ.com: http://www.wsj.com Visit the WSJ Video Center: https://wsj.com/video On Facebook: https://www.facebook.com/pg/wsj/videos/ On Twitter: https://twitter.com/WSJ On Snapchat: https://on.wsj.com/2ratjSM
Published 2016-11-23 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.





